Physician profile
Matthew Antalek
NPI 1326430166
$1,314.46
in general payments reported to CMS, 2019-2025
7 companies · $347 in 2025
The $347 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.51 · 2021: $23.55 · 2022: $57.96 · 2023: $433 · 2024: $413 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,193.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $777.28 | 2023-2025 | Therasphere Administration Set, Obsidio |
| Bard Peripheral Vascular, INC. | $204.26 | 2025 | |
| Medtronic, INC. | $152.12 | 2023-2025 | Emprint, Mvp, Endurant Iis |
| Stryker Corporation | $59.78 | 2025 | Flowtriever |
| Penumbra, INC. | $57.96 | 2022 | |
| Terumo Medical Corporation | $39.51 | 2019 | |
| Janssen Biotech, INC. | $23.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Antalek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.